PNC Financial Services Group
IPSC icon

PNC Financial Services Group’s Century Therapeutics IPSC Stock Holding History

PNC Financial Services Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,274
Closed -$3.51K – 5154
2025
Q2 		$3.51K Sell
6,274
-753
-11% -$404 ﹤0.01% 4243
2025
Q1 		$3.35K Buy
+7,027
New +$5.28K ﹤0.01% 4193

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group's IPSC Position: Q3 2025 in Review

PNC Financial Services Group sold out of Century Therapeutics (IPSC) in Q3 2025, closing a stake of 6,274 shares — an estimated $3.51K sold.

PNC Financial Services Group first reported a position in IPSC in Q1 2025 and held it in 2 quarters. The position peaked at $3.51K in Q2 2025. 57 funds tracked by Wall St. Rank hold IPSC as of Q3 2025.

  • PNC Financial Services Group reported no remaining Century Therapeutics position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 6,274 Century Therapeutics shares in Q3 2025, an estimated $3.51K.
  • PNC Financial Services Group first reported a position in Century Therapeutics in Q1 2025 and held it in 2 quarters.
  • PNC Financial Services Group's Century Therapeutics position peaked at $3.51K in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.